In recent years, multiple pharmaceutical sales representatives have pleaded guilty to charges related to health care fraud schemes. Notably:
- Steven Monaco (2022): A medical sales representative from Sewell, New Jersey, Monaco was convicted on charges including conspiracy to commit health care fraud and wire fraud. He was sentenced to 14 years in prison for his involvement in a multimillion-dollar fraud operation. IRS
- Mark Moffett (2024): Formerly a sales representative for Aegerion Pharmaceuticals, Moffett was implicated in a scheme to fraudulently obtain insurance approvals for the cholesterol drug Juxtapid. He pleaded guilty to wire fraud and agreed to forfeit $118,500 in sales bonuses. Moffett was sentenced to time served, reflecting the seven months he had already served prior to his retrial.
These cases highlight the ongoing efforts by authorities to address fraudulent activities within the pharmaceutical industry.
Please note that legal proceedings are ongoing, and details may evolve as new information emerges.